You have no items in your shopping cart.
Search results for: 'active'
- RecombinantFGF-16,Human [orb1494749]
> 95% as analyzed by SDS-PAGE and HPLC.
23 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg - RecombinantDKK-1,Mouse [orb1494754]
> 95% as analyzed by SDS-PAGE.
19-20 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg > 98% as analyzed by SDS-PAGE.
8 kDa, observed by reducing SDS-PAGE.
CHO
1 mg, 50 μg, 10 μg- RecombinantCT-1,Human [orb1494756]
> 95% as analyzed by SDS-PAGE.
24~26kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg > 98% as analyzed by SDS-PAGE.
10.5 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg> 98% as analyzed by SDS-PAGE.
7.6 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg- RecombinantVEGF121,Human [orb1494762]
> 95% as analyzed by SDS-PAGE and HPLC.
28.2 kDa, observed by non-reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg > 95% as analyzed by SDS-PAGE and HPLC.
19.6 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg> 95% as analyzed by SDS-PAGE& HPLC
17.4 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg- RecombinantTNF-α,Human [orb1494766]
> 98% as analyzed by SDS-PAGE and HPLC.
17.3 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg
